UnknownN/Aketamine

Pericapsular Nerve Group Block for Positional Pain and Postoperative Analgesia in Hip Fractures

Sponsored by Azienda Sanitaria dell'Alto Adige

NCT ID
NCT05079087
Target Enrollment
100 participants
Start Date
2021-04-01
Est. Completion
2022-11-01

About This Study

The aims of this study are: * Evaluate the effectiveness of the pericapsulare blockade of the femoral nerve, the accessory obturator nerve and the obturator nerve in patients with pertrochanteric fractures of the femur, during the pre-operative period for patient positioning manoeuvres (sitting position for performing spinal anaesthesia, mobilisation on the operating bed, etc.); * Evaluate the consumption of opioids or hypnotics in the perioperative period, which are more responsible for the incidence of delirium in the elderly patient; * Evaluate the duration and quality of postoperative analgesia and well-being.

Conditions Studied

Pertrochanteric FracturePain, Postoperative

Interventions

  • Pericapsular nerve group blockade
  • Midazolam Ketamine arm

Eligibility

Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Patients with a peritrocanteric femur fracture admitted to the orthopaedic ward

Exclusion Criteria:

* Patient refusal
* Lack of informed consent
* Pathological skin alterations
* Intertrigo at the puncture site level.
* Allergy to any of the drugs
* Coagulopathy
* Sepsis
* Use of direct oral anticoagulatns (DOACs)

Study Locations (1)

Azienda sanitaria Allo Adige ospedale di Merano
Meran, Bolzano, Italy

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source